Lawson Imaging is a recognized leader in non-invasive biomedical imaging with new developments in hybrid imaging platforms such as MR/PET, PET/CT and SPECT/CT currently being applied to the areas of cardiology, neurology (including mental health), metabolic disease and cancer. Cyclotron and radiochemistry facilities provide key resources for this research. Also at the forefront of biomedical imaging are the emerging technologies of photoacoustic and optical imaging and optical spectroscopy as well as the investigation and therapeutic application of bioelectromagnetics.
Our faculty and staff have the expertise and creativity to discover and innovate through basic research, translational research, clinical trials, and commercialization.
Our goal
To develop non-invasive capabilities and diagnostic imaging so we can better understand the fundamental mechanisms of human biology and enhance diagnosis, prevention and treatment of disease.
Our research areas
- Biolelectromagnetics
- Brain Monitoring
- Cardiac Imaging
- CT Perfusion
- Diabetes
- Duchenne Muscular Dystrophy
- Human Threshold
- Imaging Probe Development
- Photoacoustic Imaging
- Molecular Imaging
- Neonatology
- Neuropsychiatry
- Perfusion MRI
- PET/CT
- PET/MRI
- Therapeutic Brain Stimulation
Our team
The Lawson Imaging Research Program team of 30 researchers, led by Dr. Frank Prato, is a recognized world leader in non-invasive biomedical imaging. Hybrid imaging (which combines two or more imaging methods to provide superior images and diagnostic information) is currently being applied to the areas of cardiology, neurology (including mental health), metabolic disease and cancer.
